Author: admin

I forbindelse med at satsen for emissionsomkostninger samt indløsning nedsættes med 0,05% for alle afdelinger under foreningen, offentliggøres hermed ajourført investoroplysninger.Satserne for emission og indløsning for de tre afdelinger ændres således som følger:– Danske Aktier KL fra 0,15% til 0,10%– Globale Aktier KL fra 0,30% til 0,25%  – Globale Aktier Akk. fra 0,30% til 0,25%Herudover er der foretaget almindelig årlig ajourføring.Eventuelle henvendelser vedrørende denne meddelelse kan ske til Tage Fabrin-Brasted, tlf.: 44 55 92 00.Med venlig hilsenKapitalforeningen BLS InvestTage Fabrin-BrastedDirektørVedhæftet filInvestoroplysninger_BLS_02_01_2020_inkl_vedtaegter

INDKALDELSE TIL EKSTRAORDINÆR GENERALFORSAMLINGAktionærerne i Dalhoff Larsen & Hornemann A/S, CVR. nr. 34 41 19 13, (”Selskabet”) indkaldes hermed til ekstraordinær generalforsamling i Selskabet til afholdelse                                                                Fredag den 24. Januar 2020 kl. 12.00hos Visionhouse, Lyskær 8, 2730 Herlev med følgende dagsorden med forslag stillet af bestyrelsen: Forslag om ændring af selskabets navn Forslag om valg af nye...

Vast Resources plc / Ticker: VAST / Index: AIM / Sector: Mining02 01 2020Vast Resources plc(“Vast” or the “Company”)Funding UpdateVast Resources plc, the AIM-listed mining company, is pleased to announce that, further to the Company’s announcement of 18 December 2019 regarding the funding update, the Company has submitted a drawdown request for the First Tranche Issuance to Atlas Capital Markets Limited in accordance with the terms and conditions of the Bond Issuance Deed.**ENDS**For further information, visit www.vastplc.com or please contact:The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 (“MAR”).ABOUT VAST RESOURCES PLCVast Resources plc, is an AIM listed mining company...

Almere, The NetherlandsJanuary 2, 2020ASM International N.V. (Euronext Amsterdam: ASM) has received TSMC’s “Excellent Performance Award”, one of seven equipment suppliers to win this recognition in 2019. The award was presented to ASM by Mr. J.K. Wang, Senior Vice President Advanced Fab Operations, at the TSMC Supply Chain Management Forum on Dec 5, 2019, in Taiwan.The award was received by ASM in recognition of its technology collaboration with TSMC.  During the presentation, TSMC explained three points that contributed to the award to ASM.1)     Outstanding development support.2)     Continuous efforts in productivity improvement.3)     Excellent delivery support on production ramp.“On behalf of ASM and all of our employees, I thank TSMC for their...

Luxembourg – 02 January 2020 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) (the Company) today announced changes to the Executive Management Team, effective from 1 January, 2020.John Evans is now in place as Chief Executive Officer, succeeding Jean Cahuzac who retired at the end of 2019. Jean remains on the Board of the Company as a Non-Executive Director.John has a deep understanding of the Company and over 30 years’ experience in the global offshore energy services industry. Prior to his recent appointment as Chief Executive Officer, he was Chief Operating Office for Subsea 7 from 2005 to 2019.“I’m delighted to take up my new role and my priority is to lead our high-calibre leadership team into our next chapter in an evolving energy industry. We are an innovative and collaborative company with talented...

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONSNB Private Equity Partners Limited2 January 2020Total Voting RightsIn accordance with DTR 5.6.1R, NB Private Equity Partners Limited (“NBPE” or the “Company”) notifies the market of the following:As at 31 December 2019, NBPE had the following shares in issue and where appropriate admitted to trading on a regulated or prescribed market:For further information, please contact:NBPE Investor Relations                                 +1 214 647 9593Kaso Legg Communications                     ...

Zaandam, the Netherlands, January 2, 2020 – Ahold Delhaize today commences the €1 billion share buyback program announced on December 4, 2019 and expects to complete the program before the end of 2020. As indicated in our announcement on 4 December 2019, maintaining a balanced approach between funding growth in key channels and returning excess liquidity to shareholders is part of Ahold Delhaize’s financial framework to support its Leading Together strategy. The purpose of the program is to reduce the capital of Ahold Delhaize, by cancelling all or part of the common shares acquired through the program.The program will be executed by intermediaries allowing the execution of share repurchases in the open market during open and closed periods. The program will be executed within the limits of relevant...

Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for Lumoxiti® (moxetumomab pasudotox-tdfk), a first-in-class medicine indicated for adult patients with relapsed or refractory hairy cell leukemia (HCL) who have received at least two prior systemic therapies, including treatment with a purine nucleoside analog.“If approved by the EMA, Lumoxiti will be the first treatment available in Europe for relapsed or refractory hairy cell leukemia patients in more than twenty years, potentially changing the standard of care for these patients,” commented Pierre Dodion, MD, Executive Vice President and Chief Medical Officer of Innate...

Innate Pharma SA (Euronext Paris : IPH – ISIN : FR0010331421 ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui que l’Agence Européenne du Médicament (EMA) a accepté le dossier de demande d’Autorisation de Mise sur le Marché (AMM) de Lumoxiti® (moxetumomab pasudotox-tdfk), un traitement « first-in-class » pour les adultes atteints de leucémie à tricholeucocytes en rechute ou réfractaire ayant reçu précédemment au moins deux lignes de traitements, dont des analogues de nucléosides puriques.« S’il est approuvé par l’EMA, Lumoxiti sera le premier traitement disponible en Europe pour la leucémie à...

VANCOUVER, British Columbia, Jan. 02, 2020 (GLOBE NEWSWIRE) — Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based business focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales is pleased to announce entry into a Memorandum of Understanding (“MOU”) towards a distribution agreement serving key legalized European cannabis markets.Due to commercial practicalities, the currently unnamed distributor has provisionally agreed to enter an understanding with Isracann towards a strategic export and processing opportunity as part of a pending definitive agreement. The agreement in principal proposes a non-binding option on dried flower product subject to Israeli export laws and defined by minimum quantity,...